Dishman Pharmaceuticals and Chemicals on Tuesday said its Switzerland-based subsidiary Carbogen Amcis AG has acquired Creapharm Parenterals for an undisclosed amount.
“The company’s wholly owned subsidiary company, namely Carbogen Amcis AG, Switzerland, has acquired Creapharm Parenterals, a subsidiary of France-based Greapharm Group,” Dishman Pharmaceuticals and Chemicals said in a filing to the BSE.
As part of this acquisition, Creapharm Parenterals, a contract development and manufacturing firm, has changed its name to Carbogen Amics SAS, it added.
The acquisition will extend Carbogen Amics development and manufacturing services by adding complementary formulation and lyophilisation services and sterile GMP capabilities for the fast supply of drug products, including highly potents, for pre-clinical studies and clinical trials (Phase I, II & III), Dishman said.
Shares of Dishman Pharmaceuticals and Chemicals closed at Rs 47.40 apiece on the BSE today, down 0.21 per cent from their previous close.